ArticleRadiology case reports2025
Radiologic and Pathologic Insights into Medication-Related Osteonecrosis of the Jaw in Myeloma Patients: A Report of 3 Cases.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is a rare side-effect of certain drugs, mainly those used in regimens treating specific cancers and in the initial treatment for non-neoplastic conditions. The first cases of jaw osteonecrosis were reported over 2 decades ago in patients taking bisphosphonates (BPs). Since its identification, the nomenclature has changed from bisphosphonate-related osteonecrosis of the jaw (BRONJ) to MRONJ, as other drugs can elicit the same reaction. Invasive dental treatments, such as extractions, are known risk factors. Therefore, the importance of routine dental care before and during such drug therapy cannot be overemphasized. MRONJ is a challenging condition to diagnose early as the radiographic features are subtle and easily overlooked. This case report presents 3 female patients with multiple myeloma, emphasizing the chronological radiologic evolution of MRONJ. Notably, 1 case illustrates a transition from Stage 0 to Stage 2 over a 17-month period, documented through serial panoramic radiographs and a positron emission tomography (PET) scan. Another case highlights the role of cone beam computed tomography (CBCT) in identifying sequestra and pathological fractures. An additional noteworthy case illustrates that conservative dental management avoided the potential development of MRONJ. While histopathology confirmed necrotic bone in 2 cases, early radiologic indicators such as sclerosis and nonhealing sockets provided key diagnostic insights. This case report underscores the importance of regular dental monitoring and interdisciplinary care in at-risk patients and contributes to the growing discourse on the critical role of radiologic evaluation in the early detection and management of MRONJ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.